PINK
Simplify Health Care ETF
PINK is an actively managed fund of US healthcare stocks and/or ETFs. The fund seeks long-term capital growth and commits to donate its net profit, in the form of its annual management fee to the Susan G. Komen Breast Cancer Foundation.
US
EQUITY
Active
MANAGEMENT STYLE
50 bp
EXPENSES
$178.6 M
ASSETS UNDER MGMT
Fund Basics
Fund sponsor | Simplify Asset Management Inc. |
Category | US |
Asset class | Equity |
Website | link... |
Inception date | Oct 07, 2021 |
Assets (mns) | $179 |
Expense ratio | 50 bp |
Currency | USD |
Sector Breakdown
Fund Structure
Regulation | Open-Ended Fund |
Distributions | Annually |
Taxation | 1099 |
Stock selection | Proprietary |
Weighting | Proprietary |
Holdings Transparency | Full |
Derivatives-based | No |
Options available | Yes |
Currency hedged | No |
Fund of funds | No |
Top 10 Holdings
SAREPTA THERAPEUTICS INC | 9.6 % |
ELI LILLY & CO | 7.5 % |
INSMED INC | 6.8 % |
UNITEDHEALTH GROUP INC | 6.7 % |
MERCK & CO. INC. | 5.1 % |
REGENERON PHARMACEUTICALS | 5.0 % |
INTUITIVE SURGICAL INC | 4.9 % |
BOSTON SCIENTIFIC CORP | 4.6 % |
PURECYCLE TECHNOLOGIES INC | 4.5 % |
NOVO-NORDISK A/S-SPONS ADR | 4.2 % |
Constituent Breakdown
Number of holdings | 53 |
Herfindahl-Hirschman Index | 438 |
Wgt avg mkt cap (mns) | $187,907 |
Large cap (>$10bn) | 75.6% |
Mid cap ($2-10bn) | 17.2% |
Small cap (<$2bn) | 7.2% |
Developed mkts. | 100.0% |
Emerging mkts. | 0.0% |
Country Exposure
UNITED STATES | 89.8 % | |
DENMARK | 5.1 % |
Historical Performance
Standardized Performance (as of 06/30/2024)
YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | Incep. | |
---|---|---|---|---|---|---|---|
Total Returns | 15.1% | 19.2% | 13.8% | -- | -- | -- | 5.5% | Volatility | 12.2% | 12.9% | 15.6% | -- | -- | -- | -- |
Market Correlations
versus... | Beta | R-squared |
S&P 500 | 0.74 | 64% |
MSCI EAFE | 0.66 | 48% |
MSCI Emg Mkts | 0.40 | 18% |
Liquidity Measures
Avg. volume (000) | 122 |
Turnover | 2.2% |
Avg. Bid/Ask (% of price) | 0.15% |
ADV of underlying (mns) | $46,360 |
Technical Indicators
Recent close | $32.18 |
30d moving avg. | $31.41 |
Annualized volatility | 17.5% |
Relative strength (RSI) | 57 |
Short interest (ETF) | 0.6% |
Short interest (underlying) | 0.0% |
Distributions
Assets Under Management (mns)
Money Flows (mns)
Short Interest (as % of shares outstanding)
Long Money Flows (mns)
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
Ticker | Fund Name | Overlap vs. PINK |
Expenses vs. PINK |
ALTAR Score™ vs. PINK |
---|---|---|---|---|
IYH | iShares U.S. Healthcare ETF | 42.4% | -10 bp | +4.7% |
FHLC | Fidelity MSCI Health Care Index ETF | 41.4% | -42 bp | +4.3% |
VHT | Vanguard Health Care ETF | 41.1% | -40 bp | +4.1% |
XLV | Health Care Select Sector SPDR Fund | 40.4% | -41 bp | +5.6% |
IXJ | iShares Global Healthcare ETF | 35.2% | -8 bp | +4.6% |
FMED | Fidelity Disruptive Medicine ETF | 32.5% | 0 bp | -1.3% |
GDOC | Goldman Sachs Future Health Care Equity ETF | 25.6% | +25 bp | +2.2% |
FXH | First Trust Health Care AlphaDEX Fund | 25.3% | +12 bp | +5.6% |
HELX | Franklin Genomic Advancements ETF | 24.2% | 0 bp | -1.1% |
RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 23.4% | -10 bp | +6.3% |
Risk and Returns: PINK vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates
2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | ||
---|---|---|---|---|---|---|---|---|
Sales per share | -- | -- | -- | -- | -- | -- | -- | |
change (%) | -- | -- | -- | -- | -- | -- | -- | |
Earnings per share | -- | -- | -- | -- | -- | -- | -- | |
change (%) | -- | -- | -- | -- | -- | -- | -- | |
Dividends per share | -- | -- | -- | -- | -- | -- | -- | |
change (%) | -- | -- | -- | -- | -- | -- | -- | |
Book value per share | -- | -- | -- | -- | -- | -- | -- | |
change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
EPS Revision Activity (6 mo. ago = 100%)
Compound Annual Growth Rates
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
2023 | 2024E | Fwd Est | 2025E | |
Price-to-sales | --x | --x | --x | --x |
Price-to-earnings | --x | --x | --x | --x |
Price-to-cash flow | --x | --x | --x | --x |
Price-to-growth | --x | --x | --x | --x |
Price-to-book value | --x | --x | --x | --x |
Yield | --% | --% | --x | --% |
Based on closing prices from 7/25/2024
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
PINK
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Fund Rating
Our measure of an ETF's overall investment merit
ALTAR Score™
PINK
1.2%
Cat. Avg
5.7%
Fund Category: US
Avg. Return on Equity | --% |
Divided by: Fwd. P/BV | --x |
Less: Expenses | -- bp |
Equals: ALTAR Score™ | 1.2% |
Recommendation
AVOID
Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may be less relevant.
Category Overview
There are 899 funds in the US category, with an average ALTAR Score™
of 5.7% and a standard deviation of
2.4%. PINK's ALTAR Score™ is approximately
1.9 standard deviations
below
the category average. This places PINK in the 3rd percentile among funds in the category.
Consensus Recommendation
Sell-side recommendations on the ETF's individual constituents
Composite
PINK
Peer Average
Recent Trends
SELL
U/W
HOLD
O/W
BUY
Recent Trends
Breakdown
Expense Analysis
Peer Group | Active US Equity ETFs |
# of ETFs | 308 |
Avg. Expense Ratio | 67.1 bp |
Std. Deviation | 37 bp |
PINK (50 bp) Percentile rank | 32 |
Peer Group Expense Ratio Distribution
Total Cost of Ownership (TCO) Comparison
Expense (bp) (A) |
Avg. Bid/Ask (bp) (B) |
TCO (bp) (A)+(B) |
|
---|---|---|---|
PINK | 50.0 | 14.6 | 64.6 |
Peer Avg. | 69.7 | 23.8 | 93.5 |
For a detailed cost analysis of this and any other ETF use the TCO Comparison Tool .